Efficacy of behavioural activation therapy (Activate) in treating depression among substance dependent individuals


Substance dependence is a chronic relapsing condition, associated with high levels of psychopathology. On entry to drug and alcohol treatment approximately 25% of heroin users and 40% of methamphetamine users meet criteria for Major Depression (MD), and this comorbidity has been linked to poorer treatment outcomes. Despite this, the development and assessment of behavioural interventions for depression among substance users has received little empirical attention. One treatment approach that has shown promise among residential rehabilitation clients in the United States is Behavioural Activation Therapy for Depression (BATD-R; Lejuez et al, 2011). BATD-R is a structured treatment that aims to activate clients in specific ways that will increase rewarding experiences in their lives. It is more time efficient and less complex than most other treatments for depression. The current study seeks to examine the feasibility of using BATD-R among depressed opioid replacement therapy (ORT) and residential rehabilitation clients.

Project Status
Ongoing Projects
image - J. Ross Photo
Associate Investigator
Ph +61 2 9385 0333
Funding Body
National Health and Medical Research Council
image - J. Ross Photo
Associate Investigator
Ph +61 2 9385 0333
image - Kath Mills Sq
Director of Treatment Research
Ph +612 9385 0253
image - S. Kaye Photo
Senior Research and Evaluation Officer
image - Kathleen Brady Sq2
Chief Investigator
Ph +1 843 792 5205
image - Glenys Photo 2012 0
Associate Investigator
Ph 99267775
image - Work Photo J Cassar
Clinical Psychologist
Ph +612 9385 0397
image - P. Ewer Photo
Ms Philippa Ewer
Research Officer
image - S. Masters
Research Psychologist
Ph +612 9385 0212
image - I. Kihas
Research Officer
Ph +612 8936 1121

Our Research Streams